SCHEMBL602426

SCHEMBL602426

NC(CCC(N)C(=O)O)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.68
GRM8 O00222 1/20 0.68
GRM6 O15303 1/20 0.68
GRIN2D O15399 1/20 0.68
GRIN3B O60391 1/20 0.68
CYP1A2 P05177 1/20 0.68
GRIK1 P39086 1/20 0.68
GRM5 P41594 1/20 0.68
GRIA1 P42261 1/20 0.68
GRIA2 P42262 1/20 0.68
GRIA3 P42263 1/20 0.68
SLC1A3 P43003 1/20 0.68
SLC1A2 P43004 1/20 0.68
SLC1A1 P43005 1/20 0.68
GRIA4 P48058 1/20 0.68
GRIN1 Q05586 1/20 0.68
GRIN2A Q12879 1/20 0.68
GRIK2 Q13002 1/20 0.68
GRIK3 Q13003 1/20 0.68
GRIN2B Q13224 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8068164 1.00 GSR (0.68) GSRGRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL11780148 0.97 GSR (0.65) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL30473785 0.91 GSR (0.59) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL5065178 0.91 GSR (0.59) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL472936 0.88 GSR (0.56) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL25661134 0.88 GSR (0.56) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL4414003 0.88 GSR (0.56) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL17227466 0.88 GSR (0.56) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL15778941 0.88 KMT2A (0.61) GSRGRM8GRM6GRIN2DGRIN3B
SCHEMBL4414000 0.88 GSR (0.56) GSRGRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114512667-B Electrode binder, preparation method thereof, negative electrode, lithium battery and vehicle 比亚迪股份有限公司 2023-11-14 CN claimed
CN-114512667-A Electrode binder and preparation method thereof, negative electrode, lithium battery and vehicle 比亚迪股份有限公司 2022-05-17 CN claimed
CN-113549402-A Halogen-free flame-retardant electronic product melt adhesive film and preparation method thereof 中瀚新材料科技有限公司 2021-10-26 CN claimed
US-7427654-B1 Degradable polymides UNIVERSITY OF PUERTO RICO (US) 2008-09-23 US claimed
EP-4719381-A1 LIGAND-POLAR DRUG CONJUGATES Tripartite Therapeutics Inc. (TW) 2026-04-08 EP disclosed
US-20250032635-A1 LIGAND-POLAR DRUG CONJUGATES TRIPARTITE THERAPEUTICS INC. (TW) 2025-01-30 US disclosed
CN-114512667-B Electrode binder, preparation method thereof, negative electrode, lithium battery and vehicle 比亚迪股份有限公司 2023-11-14 CN disclosed
CN-114605949-B Epoxy modified polyester hot melt adhesive and preparation method thereof 中瀚新材料科技有限公司 2023-10-24 CN disclosed
CN-114605949-A Epoxy modified polyester hot melt adhesive and preparation method thereof 中瀚新材料科技有限公司 2022-06-10 CN disclosed
CN-114512667-A Electrode binder and preparation method thereof, negative electrode, lithium battery and vehicle 比亚迪股份有限公司 2022-05-17 CN disclosed
CN-113549402-B Halogen-free flame-retardant electronic product melt adhesive film and preparation method thereof 中瀚新材料科技有限公司 2021-12-21 CN disclosed
CN-113549402-A Halogen-free flame-retardant electronic product melt adhesive film and preparation method thereof 中瀚新材料科技有限公司 2021-10-26 CN disclosed
WO-1995001990-A1 HEMOREGULATORY PENTA- OR HEXAPEPTIDES NYCOMED PHARMA A.S (NO) 1995-01-19 WO disclosed
EP-0408371-B1 Hemoregulatory peptides SMITHKLINE BEECHAM CORP (US) 1994-09-28 EP disclosed
EP-0408371-A1 Hemoregulatory peptides SMITHKLINE BEECHAM CORPORATION (US) 1991-01-16 EP disclosed
US-4248966-A FROM TRIPEPTIDES IN CEPHALOSPORIUM EXTRACT MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1981-02-03 US disclosed
US-3957760-A AMINO ACID DERIVATIVES E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed
US-3951980-A 3-Substituted-8-methyl-3,8-diazabicyclo[3.2.1]octanes STANFORD RESEARCH INSTITUTE (US) 1976-04-20 US disclosed
US-3947445-A Diazabicyclooctanes and diazabicycloheptanes STANFORD RESEARCH INSTITUTE (US) 1976-03-30 US disclosed
US-3947589-A Fungicidal methods employing amino acid derivatives RIKAGAKU KENKYUSHO (JA) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250032635-A1 LIGAND-POLAR DRUG CONJUGATES CD274, SELPLG, PDCD1LG2 GSR 3890/4885GRM8 1595/4885GRM6 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.